Abbvie plans to lift $2 billion cap on deals
will lift a self-imposed $2 billion limit on acquisitions and mergers placed following a $63 billion deal for Botox maker Allergan in 2020 that shot up its debt, the company's chief executive officer told the Wall Street Journal. Chief Executive Officer Richard Gonzalez said the company now has…
#botox #allergan #richardgonzalez #wsj #humira #skyrizi #rinvoqn #nandhinisrinivasan #bengaluru #shinjiniganguli